These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3601993)

  • 41. Genetic influences on susceptibility to atherosclerosis in the young.
    Kwiterovich PO
    Bull N Y Acad Med; 1989 Dec; 65(10):1092-108; discussion 1154-60. PubMed ID: 2698247
    [No Abstract]   [Full Text] [Related]  

  • 42. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
    Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
    Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homozygous familial hypercholesterolemia.
    Diwan AG; Krishna KK; Jain MM; Arafat M; Sardesai VR; Dube MN
    J Assoc Physicians India; 2002 May; 50(5):738-9. PubMed ID: 12186142
    [No Abstract]   [Full Text] [Related]  

  • 44. The relationship of hypercholesterolemia to atherosclerosis with particular emphasis on familial hypercholesterolemia, diabetes mellitus, obstructive jaundice, myxedema, and the nephrotic syndrome.
    Stehbens WE; Wierzbicki E
    Prog Cardiovasc Dis; 1988; 30(4):289-306. PubMed ID: 3275991
    [No Abstract]   [Full Text] [Related]  

  • 45. What homozygous familial hypercholesterolemia produces and the will to withstand its complications.
    Zamirian M
    Am J Cardiol; 2011 Dec; 108(12):1840-1. PubMed ID: 22133134
    [No Abstract]   [Full Text] [Related]  

  • 46. [Familial hypercholesterolemia--not so dangerous as supposed?].
    Carlsen SM; Hetlevik I
    Tidsskr Nor Laegeforen; 2001 Mar; 121(9):1127-9. PubMed ID: 11354896
    [No Abstract]   [Full Text] [Related]  

  • 47. Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches.
    Jebari-Benslaiman S; Larrea-Sebal A; Benito-Vicente A; Martín C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The laboratory rabbit: an animal model of atherosclerosis research.
    Yanni AE
    Lab Anim; 2004 Jul; 38(3):246-56. PubMed ID: 15207035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Familial hypercholesterolemia and cardiovascular disease a top concern for women.
    Gish BA
    Nurs Womens Health; 2009 Feb; 13(1):30-7. PubMed ID: 19207502
    [No Abstract]   [Full Text] [Related]  

  • 50. Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies.
    Thim T; Hagensen MK; Drouet L; Bal Dit Sollier C; Bonneau M; Granada JF; Nielsen LB; Paaske WP; Bøtker HE; Falk E
    EuroIntervention; 2010 Jun; 6(2):261-8. PubMed ID: 20562079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Incidence of dyslipoproteinemias in familial epilepsy].
    Havlová M; Sobra J
    Cesk Pediatr; 1987 Dec; 42(12):707-11. PubMed ID: 3442851
    [No Abstract]   [Full Text] [Related]  

  • 52. [How common is familial hypercholesterolemia?].
    Svare A
    Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2134. PubMed ID: 12555654
    [No Abstract]   [Full Text] [Related]  

  • 53. Apolipoprotein AI mRNA levels in WHHL rabbits.
    Saku K; Harada R; Yamamoto K; Ying H; Ozaki I; Arakawa K
    Atherosclerosis; 1990 Sep; 84(1):73-4. PubMed ID: 2123385
    [No Abstract]   [Full Text] [Related]  

  • 54. Arterial compliance: a tool in the evaluation of vascular disease in familial hypercholesterolemia.
    Marques da Silva P
    Atherosclerosis; 2000 Feb; 148(2):437-40. PubMed ID: 10657583
    [No Abstract]   [Full Text] [Related]  

  • 55. [Animal models for spontaneous hyperlipidemia].
    Shiomi M; Ito T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():617-20. PubMed ID: 11351660
    [No Abstract]   [Full Text] [Related]  

  • 56. Is there a relationship in pathogenesis between arteriosclerosis and familial hypercholesteremia?
    THANNHAUSER SJ
    Bull New Engl Med Cent; 1950 Aug; 12(4):129-33. PubMed ID: 15434572
    [No Abstract]   [Full Text] [Related]  

  • 57. Challenges in reducing atherosclerotic inflammation in patients with familial hypercholesterolemia.
    Montecucco F; Carbone F; Liberale L; Sahebkar A
    Eur J Prev Cardiol; 2020 Dec; 27(19):2099-2101. PubMed ID: 31288540
    [No Abstract]   [Full Text] [Related]  

  • 58. Mitral valve disease in a patient with familial hypercholesterolemia.
    Rajamannan NM; Spelsberg TC; Moura LM
    Rev Port Cardiol; 2010 May; 29(5):841-2. PubMed ID: 20866011
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of Twitter to Promote Awareness of Familial Hypercholesterolemia.
    Bangash H; Khan F; He B; Arce M; Kullo IJ
    Circ Genom Precis Med; 2019 Jul; 12(7):e002550. PubMed ID: 31306057
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypercholesterolaemia project.
    Berger GM
    S Afr Med J; 1979 Dec; 56(24):1021-2. PubMed ID: 550434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.